Skip to content
10-Q

Quarterly Report

VANSEN PHARMA INC.

0001477932-13-002256

← back to feed
Filed
May 9, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 9, 2013 3.53M sh
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$7.71K
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$223.9K
Operating Cash Flow Q1 2013 · Mar 31, 2012 −$8.83K
Cash And Equivalents Q1 2013 · Mar 31, 2013 $7.31K
Cash And Equivalents Q1 2013 · Dec 31, 2012 $15.02K
Cash And Equivalents Q1 2013 · Mar 31, 2012 $9.94K
Cash And Equivalents Q1 2013 · Dec 31, 2011 $18.77K
Stockholders Equity Q1 2013 · Mar 31, 2013 −$108.77K
Stockholders Equity Q1 2013 · Dec 31, 2012 −$104.46K
Current Liabilities Q1 2013 · Mar 31, 2013 $116.08K
Current Liabilities Q1 2013 · Dec 31, 2012 $119.48K
Total Liabilities Q1 2013 · Mar 31, 2013 $116.08K
Total Liabilities Q1 2013 · Dec 31, 2012 $119.48K
Current Assets Q1 2013 · Mar 31, 2013 $7.31K
Current Assets Q1 2013 · Dec 31, 2012 $15.02K
Total Assets Q1 2013 · Mar 31, 2013 $7.31K
Total Assets Q1 2013 · Dec 31, 2012 $15.02K
Sga Expense Q1 2013 · Mar 31, 2013 $357
Sga Expense Q1 2013 · Mar 31, 2013 $59.11K
Sga Expense Q1 2013 · Mar 31, 2012 $3.38K
Net Income Q1 2013 · Mar 31, 2013 −$6.01K
Net Income Q1 2013 · Mar 31, 2013 −$256.08K
Net Income Q1 2013 · Mar 31, 2012 −$12.14K